Zobrazeno 1 - 10
of 386
pro vyhledávání: '"sputnik v"'
Autor:
Ekaterina A. Astakhova
Publikováno v:
Инфекция и иммунитет, Vol 14, Iss 3, Pp 465-470 (2024)
The protective properties of long-term immunological memory after vaccination against COVID-19 are characterized by the neutralizing activity of serum antibodies and antibodies secreted by memory B cells upon repeated encounter with the antigen. Soma
Externí odkaz:
https://doaj.org/article/8ea1004ca4934ebcbaa0a35b58e630b3
Autor:
M. K. Erofeeva, O. V. Gashinskaya, Zh. V. Buzitskaya, T. G. Zubkova, E. V. Shakhlanskaya, M. A. Stukova, D. A. Lioznov
Publikováno v:
Эпидемиология и вакцинопрофилактика, Vol 22, Iss 6, Pp 81-89 (2024)
Relevance. The emergence of a new SARS-COV-2 coronavirus in early 2020 radically changed the seasonal pattern of influenza and other acute respiratory infections worldwide. Along with a decrease in the frequency of RSV infection, the number of diagno
Externí odkaz:
https://doaj.org/article/a7a0b58f38e84d18ad13ad35b47eac06
Autor:
Christopher Franco, Alejandro Cornejo, Mariajosé Rodríguez, Alexis García, Inirida Belisario, Soriuska Mayora, Domingo José Garzaro, Rossana Celeste Jaspe, Mariana Hidalgo, Nereida Parra, Ferdinando Liprandi, José Luis Zambrano, Héctor Rafael Rangel, Flor Helene Pujol
Publikováno v:
Viruses, Vol 16, Iss 9, p 1480 (2024)
The COVID-19 pandemic was characterized by the emergence and succession of SARS-CoV-2 variants able to evade the antibody response induced by natural infection and vaccination. To evaluate the IgG reactivity and neutralizing capacity of the serum of
Externí odkaz:
https://doaj.org/article/3ab4adcf37794174a8b0c1c8c7e0bd2a
Publikováno v:
Научно-практическая ревматология, Vol 61, Iss 3, Pp 268-275 (2023)
The aim of the study was to assess the safety of the combined vector vaccine Gam-COVID-Vac (Sputnik V) and to determine the risk factors for the development of adverse events in patients with immuno-inflammatory rheumatic diseases (IIRD). Patients an
Externí odkaz:
https://doaj.org/article/2dcd2b27c2b84baba78de461f1dba9fd
Autor:
Ommolbanin Younesian, Behnaz Khodabakhshi, Sara Hosseinzadeh, Seyedeh Somayeh Hosseini Alarzi, Samareh Younesian, Mojtaba Pourmomen, Mana Zakeri, ali hosseini, hamidreza joshaghani
Publikováno v:
Medical Laboratory Journal, Vol 17, Iss 5, Pp 9-11 (2023)
Background: Although public health interventions have slowed the spread of SARS CoV 2 infections, the worldwide pandemic of COVID 19 is progressing. Thus, effective and safe vaccination against SARS CoV 2 is an important tool for controlling the COVI
Externí odkaz:
https://doaj.org/article/13e01b019dee44d7b1165ec088b39517
Publikováno v:
Эпидемиология и вакцинопрофилактика, Vol 22, Iss 1, Pp 28-37 (2023)
Relevance. Many countries around the world are developing effective vaccines against SARS-CoV-2. The measure of the effectiveness of the vaccination process has traditionally been antibody production. The frequency and intensity of adverse reactions
Externí odkaz:
https://doaj.org/article/adc45a0f502847d18ee30a0204b2814b
Autor:
Atieh Yaghoubi, Samira Asli, Maryam Parhizkar, Maryam Mohammadpour, Ali Khorsand, Mehdi Yousefi, Taravat Bamdad, Saeid Amel Jamehdar
Publikováno v:
Iranian Journal of Immunology, Vol 20, Iss 1, Pp 76-82 (2023)
Background: Measuring the level of antibodies produced post-vaccination in response to the SARS-CoV-2 spike protein is considered a strategy for estimating the effectiveness of the COVID-19 vaccines.Objective: To examine the antibody levels among the
Externí odkaz:
https://doaj.org/article/aa91cca0575a4cf289c80869b92a5c8f
Autor:
Mostafa Enayatrad, Sepideh Mahdavi, Roqayeh Aliyari, Sajad Sahab-Negah, Sairan Nili, Mohammad Fereidouni, Parvin Mangolian Shahrbabaki, Alireza Ansari-Moghaddam, Abtin Heidarzadeh, Fariba Shahraki-Sanavi, Mansooreh Fateh, Hamidreza Khajeha, Zahra Emamian, Elahe Behmanesh, Hossein Sheibani, Maryam Abbaszadeh, Reza Jafari, Maryam Valikhani, Ehsan Binesh, Hamid Vahedi, Reza Chaman, Hamid Sharifi, Mohammad Hassan Emamian
Publikováno v:
BMC Infectious Diseases, Vol 23, Iss 1, Pp 1-15 (2023)
Abstract Background This study aimed to evaluate the reactogenicity effects of COVID-19 vaccines, used in Iran. Methods At least 1000 people were followed up with phone calls or self-report in a mobile application within 7 days after vaccination. Loc
Externí odkaz:
https://doaj.org/article/e63601461800463f9f50a4d29f502271
Autor:
Ramani, Samuel, author
Publikováno v:
Russia in Africa : Resurgent Great Power or Bellicose Pretender?, 2023.
Externí odkaz:
https://doi.org/10.1093/oso/9780197744598.003.0009